Back to Journals » Biologics: Targets and Therapy » Volume 2 » Issue 1

Review

Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)

       
Total article views   HTML views PDF downloads Totals
7,959 Dovepress* 7,959+ 1,997 9,956
Totals 7,959 1,997 9,956
*Since 7 March 2008
+Since July 2016

View citations on Google Scholar